$MREO Cashflow Statement | Understand Stock

$MREO

$0.29 +$0.02 (6.07%) Close

$MREO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
(Loss)/profit before tax
Depreciation of property, plant and equipment
Share-based payments expense
Net foreign exchange (gain)/loss
Increase in provisions and other liabilities
Finance income
Finance costs
Other non-cash movements
Fair value remeasurement on warrants
Other income and expenses
(Gain)/loss on disposal of intangible assets
Out-license of intangible asset
Decrease/(increase) in receivables and prepayments
Increase/(decrease) in trade and other payables and accruals
Taxation
Net cash flows used in operating activities
Purchase of property, plant and equipment
Proceeds from intangible assets (net of transaction costs)
Interest earned
Payments to CVR holders
Net cash flows (used in)/from investing activities
Proceeds from issuance of ordinary shares
Transaction costs on issuance of shares
Proceeds from exercise of employee share options
[Proceeds from TAP agreement]
Payment of lease liabilities
Net cash flows (used in)/from financing activities
Net (decrease)/increase in cash and cash equivalents
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation
Depreciation
Amortization of intangible assets
Amortization of operating lease right-of-use assets
Change in fair value of warrants
Interest income
Non-cash interest income
Non-cash interest expense
Foreign currency transaction loss/(gain)
Other income
Non-cash consideration, milestone payment
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Research and development incentives receivable
Accounts payable
Accrued expenses and other liabilities
Operating lease liabilities
Net cash used in operating activities
Cash flows from investing activities
Purchase of intangible assets
Purchase of property and equipment
Proceeds from out-licensing
Net cash used in investing activities
Cash flows from financing activities
Proceeds from financing agreement with TAP
Proceeds from exercise of warrants
Proceeds from issuance of ordinary shares
Transaction costs on issuance of ordinary shares
Transaction costs on convertible loan notes
Redemption of convertible loan notes
Net cash provided by financing activities
(Decrease)/increase in cash and cash equivalents
Cash and cash equivalents at January 1
Effect of exchange rate changes
Increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at December 31
Supplemental disclosure
Cash paid for interest
Cash paid/(received) for income taxes
Cash paid for the amounts included in the measurement of operating lease liabilities
Supplemental disclosure of non-cash investing and financing activities
Conversion of notes into ordinary shares

Comments